SynthesisScientific reports2019

Efficacy and safety of GLP-1 receptor agonists as add-on to SGLT2 inhibitors in type 2 diabetes mellitus: A meta-analysis.

Marco Castellana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.